Seeking to deliver skincare treatments in a way that doesn’t involve needles or creams, two MIT grads started developing a device five years ago that delivers over the counter skincare actives by penetrating the skin with a fast-moving mist. Now, the recently launched technology holds promise to revolutionize how medication and other sought-after nutrients reach the body.
Called Droplette, the innovative device is the brainchild of Madhavi Gavini and Rathi Srinivas, both MIT-trained chemical engineers. “Unlike needles, we’re not poking your skin, so you don’t have bleeding or scarring or infection risks,” Gavini said. Instead, the device uses a painless micro-mist which delivers molecules in tiny droplets through the skin.
While the current version of Droplette, sold for $299, focuses on the delivery of skincare actives, the two founders are working on tweaking the device so it delivers medication too.
After attracting attention from a number of renowned scientific institutes, including the National Institute of Health and NASA, Droplette managed to raise nearly $10 million in funding, helping the two entrepreneurs get their product on the market.
Dermatologists from Harvard and MIT are among those who have tested the product and serve on the company’s scientific advisory board, while the Walter Reed Army Institute is now planning to use the startup’s state-of-the-art technology to treat soldiers’ blast wounds.
To learn more about the technology’s potential to revolutionize not only the skincare industry but also dermatology as a whole, follow the source article below.
